ARGENX SE is 19.5x more valuable than Adaptive Biotechnologies Corp by market capitalization ($53.35 B vs $2.73 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ADPT | ARGX |
|---|---|---|
| Market cap | $2.73 B | $53.35 B |
| US-listed rank | #1887 | #306 |
| Revenue (latest FY) | $276.98M | - |
| Net income (latest FY) | -$59.50M | - |
| Net margin | -21.5% | - |
| SEC filings | 764 | 272 |
ARGENX SE is 19.5x more valuable than Adaptive Biotechnologies Corp by market capitalization ($53.35 B vs $2.73 B).
Full pages: Adaptive Biotechnologies Corp and ARGENX SE, or browse the full rankings.